Figure 4: Impact of GLC and GLC Receptor Antagonist on Cardiac Function and Chamber Dilation in Post-Myocardial Heart
GaoChen
RenShuxun Vincent
YuJunyi
BaalUlysis
ThaiDung
LuJohn
ZengChunyu
YanHai
WangYibin
2019
<b>(A)</b> Fractional shortening and <b>(B)</b> left ventricular end-systolic dimension (LVESD) in MI hearts treated with PBS (Control; n = 10, <b>blue</b>), GLC (n = 6, <b>purple</b>), and GLC receptor antagonist (REMD; n = 11; <b>red</b>) at different time points recorded by echocardiogram. #p < 0.05 REMD versus Control; REMD versus GLC. <b>(C)</b> Left ventricular developed pressure (LVDP). <b>(D)</b> Left ventricular systolic pressure (LVSP). <b>(E)</b> Maximum pressure derivative (+dP/dtmax) and <b>(F)</b> Minimum pressure derivative (–dP/dtmin) as measured by conductance catheter. Abbreviations as in Figure 1.